لندبيك إكسبورتس أيه أس
لندبيك إكسبورتس أيه أس المعلومات| النشاط التجاري / الفئة: | الخدمات الطبية ومستلزماتها > ادوية - منتجات |
|---|
| المدينة: | دبي |
|---|
| البلد: | الإمارات العربية المتحدة |
|---|
| الهاتف: | |
|---|
| الفاكس: | |
|---|
| ص.ب: | 49886 |
|---|
| الموقع: | 902, Saeed Tower 2, Sheikh Zayed Road |
|---|
| الموقع الإلكتروني: | www.lundbeck.com |
|---|
The positive momentum continues
Download the report
Brain disorders cover a number of diseases that may be clasified as psychiatric and neurological disorders. Read more about the diseases that Lundbeck is working with.
Read more
Improving lives for almost a century
See the Lundbeck history
at 16:59 107.3 DKK -0.093%
خريطة الموقع
902, Saeed Tower 2, Sheikh Zayed Road
دبي
الإمارات العربية المتحدة
لندبيك إكسبورتس أيه أس
902, Saeed Tower 2, Sheikh Zayed Road
الكلمات المفتاحية:
lundbeck, releases, disorders, corporate, read, global, united, contacts, brain, worldwide, website, view, responsibility, psychiatric, lundbecks, history, diseases, denmark, country, career, africa, years, world, working, websites, watch, visit, video, venezuela, valby, turkey, treatment, transactions, targeting, switzerland, sweden, success, states, spain, south, slovenia, slovakia, sites, sitemap, sign, shares, share, serbia, securities, schizophrenia, russia, results, research, republic, report, remain, region, refer, record, quotokquot, quotcancelquot, quick, provided, price, presentation, positive, portugal, poland, phone, pharmaceuticals, pharmaceutical, persons, patients, partnering, page, overview, outside, ottiliavej, otsuka, operate, oceania, number, norway, neurological, netherlands, movie, momentum, modified, mexico, medicines, media, maintenance, long, lives, list, linked, link, legal, latvia, latest, korea, kingdom, japan, italy, ireland, investor, institute, innovative, india, improving, historic, greece, germany, france, foundation, formulation, finland, financial, executives, europe, estonia, entities, emirates, download, does, disclaimer, development, depot, deliver, december, czech, cover, countries, continues, continue, content, contact, considering, commercialisation, colombia, closely, close, click, clasified, chosen, choose, china, chile, century, canada, bulgaria, brazil, austria, australia, associated, asia, aripiprazole, argentina, arab, announcement, america, agreement, adult, accepted, http://www.lundbeck.com//content/images/logo.png, View contacts, View all releases, Venezuela, United States, United Kingdom, United Arab Emirates, Turkey, Switzerland, Sweden, Spain, South Africa, Slovenia, Slovakia, Sitemap, Serbia, See the Lundbeck history, Russia, Read more, Read more, Read more, Portugal, Poland, Oceania, Norway, Netherlands, NDA for aripiprazole depot formulation for maintenance treatment of adult patients with schizophrenia accepted by the FDA, Mexico, Media, LUNDBECK WORLDWIDE, Lundbeck and Otsuka Pharmaceutical sign historic agreement to deliver innovative medicines targeting psychiatric disorders worldwide, Latvia, Korea, Japan, Italy, Ireland, Investor, India, Greece, Germany, France, Finland, Europe, Estonia, Download the report, Disclaimer, Denmark, Czech Republic, Corporate Responsibility, Contact us, Colombia, Close, China, Chile, Career, Canada, Bulgaria, Brazil, Brain disorders, Austria, Australia, Asia, Argentina, Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities, America, Africa, About us, Lundbeck Institute, Lundbeck Foundation, SHARE PRICE, Q3 Financial results, Partnering with us, Our corporate movie, Latest releases, Considering a career at Lundbeck?, Choose region and then country, Brain disorders, 96 years of history, Other Lundbeck sites, NDA for aripiprazole depot formulation for maintenance treatment of adult patients with schizophrenia accepted by the FDA, Lundbeck and Otsuka Pharmaceutical sign historic agreement to deliver innovative medicines targeting psychiatric disorders worldwide, Global contacts, Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities